Skip to content

A randomised controlled trial of a supervised exercise programme as a rehabilitation treatment for women receiving early stage breast cancer treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN12587864
Enrollment
182
Registered
2006-01-20
Start date
2004-01-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer Cancer Breast

Interventions

Intervention: Group exercise class twice a week for 12 weeks The control group will receive usual care from the healthcare team and will complete the questionnaires and walking test at baseline, week

Sponsors

University of Strathclyde (UK)
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Any women undergoing treatment for early stage breast cancer.

Exclusion criteria

Exclusion criteria: Any woman with concurrent major health problems such as uncontrolled cardiac or hypertensive disease, respiratory disease, cognitive dysfuntion or already exercising vigorously three times a week for 20 minutes or more.

Design outcomes

Primary

MeasureTime frame
Functional assessment of cancer therapy - general (FACT G) - measure of Quality of life

Secondary

MeasureTime frame
1. FACT - breast cancer specific 2. FACT - fatigue 3. FACT - endocrine symptoms 4. Beck Depression Inventory (BDI) 5. Positive and Negative Affects Scale (PANAS) 6. 12 minute walk test 7. Scottish physical activity questionnaire (SPAQ)

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 8, 2026